Jci_page_head_homepage_01 Jci_page_head_homepage_02
Oliver G. Opitz, Yasir Suliman, William C. Hahn, Hideki Harada, Hubert E. Blum, Anil K. Rustgi
Published in Volume 108, Issue 5
J Clin Invest. 2001; 108(5):725–732 doi:10.1172/JCI11909
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 1

Effects of cyclin D1 overexpression and/or dominant-negative p53 expression in oral keratinocytes (OKF6). (a) Equal amounts of protein for parental OKF6, OKF6-Δp53, OKF6-D1, and OKF6-D1/Δp53 were separated on a 10% SDS-PAGE. The level of cyclin D1 overexpression was compared by subsequent immunoblot analysis using polyclonal cyclin D1 antibody (H295) and monoclonal cyclin D1 antibody (HD11) (data not shown). (b) Equal amounts of protein for parental OKF6, OKF6-D1, OKF6-Δp53, and OKF6-D1/Δp53 were separated on a 10% SDS-PAGE. Subsequent immunoblot was done with two different conformational p53 antibodies: the monoclonal p53 antibody 421 and the monoclonal p53 antibody 122. The human epidermoid cancer cells A431 served as positive control.